Metropolis Healthcare s Q4 results show 10% YoY increase in overall revenue, 15% YoY growth in core business revenue. During the current quarter, the company has repaid debt, resulting in a debt-free status as of March 31, 2024.
Hot stocks today: Indian equity benchmarks were trading lower today. The 30-share BSE Sensex fell 183 points to 65,445 and Nifty lost 66 pts to 19,558. Here s a look at stocks that are buzzing in action today.
The brokerage has a sell call on Dr Lal with a target price of ₹1,740, implying a potential downside of over 30 percent. Meanwhile, it has a reduce call on Metropolis with a target price of ₹1,350, indicating an over 7 percent downside.